Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option

Purpose: The recurrent/progressive glioblastoma multiforme (GBM) carries a dismal prognosis and the definitive treatment strategy has not yet been established. This study aimed to assess the efficacy and safety of apatinib in recurrent/progressive GBM patients.Materials and methods: The clinical dat...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Hong-Hong Zhang, Xiao-Jing Du, Mei-Ling Deng, Lie Zheng, Dun-Chen Yao, Zhi-Qiang Wang, Qun-Ying Yang, Shao-Xiong Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	apatinib recurrent/progressive glioblastoma multiforme efficacy safety VEGFR
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.969565/full